MEDOVEX CORP (MDVX) financial statements (2021 and earlier)
Company profile
| Business Address |
201 E KENNEDY BLVD STE 700 TAMPA, FL 33602 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 368 | 300 | 2,592 | 47 | 228 | 114 | 126 | ||
| Cash and cash equivalents | 368 | 300 | 2,592 | 47 | 228 | 114 | 126 | ||
| Receivables | 71 | 80 | 158 | 146 | 151 | 189 | 270 | ||
| Inventory, net of allowances, customer advances and progress billings | 126 | 129 | 129 | 131 | 206 | 294 | 306 | ||
| Inventory | 126 | 129 | 129 | 131 | 206 | 294 | 306 | ||
| Prepaid expense | 199 | 295 | 365 | 46 | 59 | 111 | 140 | ||
| Total current assets: | 764 | 804 | 3,244 | 371 | 644 | 708 | 843 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 859 | 973 | 1,092 | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 235 | 259 | 275 | 30 | 67 | 73 | 80 | ||
| Intangible assets, net (including goodwill) | 15,692 | 14,661 | 8,630 | ||||||
| Goodwill | 12,564 | 11,349 | 5,134 | ||||||
| Intangible assets, net (excluding goodwill) | 3,128 | 3,312 | 3,496 | ||||||
| Deposits noncurrent assets | 3 | 3 | 3 | 3 | |||||
| Other noncurrent assets | 29 | 29 | 41 | ||||||
| Total noncurrent assets: | 16,816 | 15,923 | 10,037 | 33 | 69 | 76 | 83 | ||
| TOTAL ASSETS: | 17,580 | 16,726 | 13,282 | 404 | 714 | 784 | 926 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2,679 | 1,387 | 1,584 | 1,575 | 1,157 | 763 | 672 | ||
| Accounts payable | 1,953 | 717 | 941 | 751 | 689 | 493 | 511 | ||
| Accrued liabilities | 543 | 422 | 273 | 211 | 243 | 190 | 90 | ||
| Employee-related liabilities | 170 | 451 | 125 | ||||||
| Interest and dividends payable | 184 | 247 | 199 | 162 | 100 | 80 | 71 | ||
| Deferred revenue | 1,365 | 838 | 396 | ✕ | ✕ | ✕ | ✕ | ||
| Debt | 1,328 | 1,302 | 1,294 | 697 | 587 | 188 | 387 | ||
| Due to related parties | 1,250 | 91 | 70 | 35 | 13 | ||||
| Other liabilities | 532 | 733 | 228 | ||||||
| Other undisclosed current liabilities | 114 | 37 | |||||||
| Total current liabilities: | 7,268 | 4,260 | 3,501 | 2,400 | 1,814 | 986 | 1,072 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 419 | 512 | 630 | 6 | 22 | ||||
| Long-term debt, excluding current maturities | 23 | 6 | 22 | ||||||
| Operating lease, liability | 396 | 512 | 630 | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed noncurrent liabilities | 332 | 0 | 0 | 0 | 0 | ||||
| Total noncurrent liabilities: | 751 | 512 | 630 | 0 | 0 | 6 | 23 | ||
| Other undisclosed liabilities | (0) | ||||||||
| Total liabilities: | 8,020 | 4,772 | 4,131 | 2,401 | 1,814 | 992 | 1,095 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 9,561 | 11,954 | 9,151 | (1,997) | (1,101) | (207) | (169) | ||
| Common stock | 99 | 99 | 94 | 25 | 24 | 23 | 23 | ||
| Additional paid in capital | 25,819 | 25,706 | 17,611 | 35,812 | 35,205 | 34,927 | 33,879 | ||
| Accumulated deficit | (15,988) | (13,481) | (8,183) | (37,834) | (36,329) | (35,157) | (34,071) | ||
| Other undisclosed stockholders' equity attributable to parent | (370) | (370) | (370) | 0 | 0 | 0 | |||
| Other undisclosed stockholders' equity | 0 | ||||||||
| Total stockholders' equity: | 9,561 | 11,954 | 9,151 | (1,997) | (1,101) | (207) | (169) | ||
| TOTAL LIABILITIES AND EQUITY: | 17,580 | 16,726 | 13,282 | 404 | 714 | 784 | 926 | ||
Income statement (P&L) ($ in thousands)
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 2,742 | 2,432 | 1,324 | 213 | 209 | 252 | 144 | |
| Cost of revenue | (550) | (492) | (559) | (77) | (122) | (205) | (98) | |
| Cost of goods and services sold | (550) | (492) | (98) | |||||
| Other undisclosed gross profit | 6 | (3) | (3) | (1) | ||||
| Gross profit: | 2,192 | 1,940 | 765 | 142 | 84 | 45 | 45 | |
| Operating expenses | (5,619) | (7,159) | (4,367) | (1,446) | (1,212) | (1,092) | (1,293) | |
| Operating loss: | (3,427) | (5,219) | (3,602) | (1,304) | (1,128) | (1,047) | (1,248) | |
| Nonoperating income (expense) | 803 | (78) | 92 | (6) | 4 | 5 | 6 | |
| Foreign currency transaction gain, before tax | 9 | 4 | 5 | 0 | ||||
| Interest and debt expense | (80) | (87) | (92) | (89) | (40) | (27) | (1) | |
| Net loss: | (2,704) | (5,384) | (3,602) | (1,398) | (1,164) | (1,069) | (1,243) | |
| Other undisclosed net income (loss) attributable to parent | 80 | 87 | (93) | 2 | (8) | (17) | (11) | |
| Net loss attributable to parent: | (2,624) | (5,297) | (3,695) | (1,397) | (1,172) | (1,086) | (1,254) | |
| Preferred stock dividends and other adjustments | (21) | (21) | (25) | (39) | (12) | (8) | ||
| Other undisclosed net loss available to common stockholders, basic | (437) | (252) | (259) | |||||
| Net loss available to common stockholders, diluted: | (2,645) | (5,318) | (4,156) | (1,687) | (1,184) | (1,353) | (1,254) | |
Comprehensive Income ($ in thousands)
| 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | 3/31/2018 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (2,704) | (5,384) | (3,602) | (1,398) | (1,164) | (1,069) | (1,243) | |
| Comprehensive loss, net of tax, attributable to parent: | (2,704) | (5,384) | (3,602) | (1,398) | (1,164) | (1,069) | (1,243) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.